Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14725679 | 0.82 | HTT (0.38) | ALDH1A1MAPTHPGDRAB9AALOX5 | |
| SCHEMBL14725633 | 0.82 | ADORA3 (0.36) | ALDH1A1MAPTHPGD | |
| SCHEMBL14725669 | 0.81 | SIRT2 (0.33) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL14725659 | 0.79 | KDM4E (0.37) | ALDH1A1MAPT | |
| SCHEMBL14725643 | 0.76 | ADORA3 (0.37) | MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL14725653 | 0.74 | CYP11B1 (0.45) | ALDH1A1HPGDBRAF | |
| SCHEMBL14725637 | 0.74 | CYP11B1 (0.39) | BRAF | |
| SCHEMBL17692088 | 0.74 | NQO2 (0.41) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL14725649 | 0.74 | CYP11B2 (0.41) | — | |
| SCHEMBL14101479 | 0.72 | GPR3 (0.45) | GPR3ALDH1A1MAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255084-B2 | Heterocyclic compound and organic light-emitting device containing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-09 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | TRPC1, TRPC4, TRPC6 | GPR3 3596/4885ALDH1A1 813/4885MAPT 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.